Identity
- Trade Name
- NX3 FDA UDI
- Generic Name
- Dental cement trial FDA UDI
- Device Name
- Try-In Gel; Syringe; Bleach; Refill FDA UDI
- Model / Reference
- 33660 FDA UDI
- Description
- Try-In Gel; Syringe; Bleach; Refill FDA UDI
Identifiers
- Catalog Number
- 33660 FDA UDI
- Primary DI / UDI-DI
- 00841396105166 FDA UDI
- FDA Product Code
- EMA FDA UDI
- GMDN Term
- Dental cement trial FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 872.3275 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Dimensions & Sizes
- Size
- Weight — 3 Gram FDA UDI
Category: Dental cement trial
Nx3 by Kerr Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Dental cement trial.
- Choice 2 Try-In Paste — BISCO INC. · Class II
- eCement Try-In Paste — BISCO INC. · Class I
- Choice 2 Try-In Paste — BISCO INC. · Class II
- G-CEM LinkForce™ — Gc America Inc. · Class II
- eCement Try-In Paste — BISCO INC. · Class I
- Choice 2 Try-In Paste — BISCO INC. · Class II
- Choice 2 Try-In Paste — BISCO INC. · Class I
- Superdent® Pressure Indicator Paste — Dentsply International · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Kerr Corporation
Sources (1)
- FDA UDI 0fa40d49-d3ea-4b8c-a495-11830fb2af39 37 fields · synced Jun 8, 2026